Literature DB >> 17141149

Oncogene addiction: role of signal attenuation.

Anette Hübner1, Anja Jaeschke, Roger J Davis.   

Abstract

Tumors can become dependent upon signaling by oncogenes. In a recent issue of Cancer Cell, Sharma et al. (2006b) reported that "oncogene addiction" may be mediated by differential rates of signal attenuation of proapoptotic and prosurvival pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141149     DOI: 10.1016/j.devcel.2006.11.006

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  4 in total

1.  Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.

Authors:  Tri Nguyen; Elisa Hawkins; Akhil Kolluri; Maciej Kmieciak; Haeseong Park; Hui Lin; Steven Grant
Journal:  Leuk Res       Date:  2014-11-11       Impact factor: 3.156

2.  RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.

Authors:  Won-Il Kim; Ilze Matise; Miechaleen D Diers; David A Largaespada
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

3.  Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.

Authors:  C Li; S Fan; T K Owonikoko; F R Khuri; S-Y Sun; R Li
Journal:  Oncogene       Date:  2011-04-11       Impact factor: 9.867

Review 4.  Role of microRNA-129 in cancer and non-cancerous diseases (Review).

Authors:  Bingpeng Deng; Xuan Tang; Yong Wang
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.